# QCR Holdings Inc: Form 10-Q for the period ended Sep 30, 2025

- Company: [QCR Holdings Inc](/companies/qcrh.md) (CIK 906465)
- Form: 10-Q
- Filed: 2025-11-07
- Accepted by EDGAR: Nov 7, 2025, 16:11 ET
- Period: 2025-09-30
- Accession: 0001104659-25-108483
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906465/000110465925108483/qcrh-20250930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906465/000110465925108483/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $5.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $36.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | $91.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $5.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $5.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 17,015,730 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 17,011,877 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $86.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $42.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Total assets | at 2025-09-30 | $9.57bn | us-gaap:Assets |
| Total liabilities | at 2025-09-30 | $8.48bn | us-gaap:Liabilities |
| Short-term borrowings | at 2025-09-30 | $2.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-09-30 | $1.09bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,635 characters.

On May 19, 2022, the board of directors of the Company approved a share repurchase program under which the Company is authorized to repurchase, from time to time as the Company deems appropriate, up to 1,500,000 shares of its outstanding common stock, or approximately 10% of the outstanding shares as of December 31, 2021. 115,735 shares of common stock were repurchased under the share repurchase program during the third quarter of 2025. All shares repurchased under the share repurchase program during the third quarter were retired. On October 20, 2025, board of directors of the Company approved a new share repurchase program under which the Company is authorized to repurchase, from time to time as the Company deems appropriate, of up to 1,700,000 shares of its common stock, or approximately 10% of the outstanding shares as of September 30, 2025. The new share repurchase program does not have an expiration date, and replaced the share repurchase program approved in 2022.

| ​ ​ ​ ​ Period ​ | ​ ​ ​ ​ ​ | ​ ​ ​ Total number of shares purchased ​ | ​ ​ ​ ​ ​ ​ | ​ ​ ​ ​ ​ ​ ​ Average price paid per share ​ ​ | ​ ​ ​ ​ ​ | ​ Total number of shares purchased as part of publicly announced plans or programs ​ | ​ ​ ​ ​ ​ | ​ Maximum number of shares that may yet be purchased under the plans or programs ​ | ​ ​ ​ ​ |
| --- | --- | ---: | --- | --- | --- | ---: | --- | ---: | --- |
| July 1-31, 2025 | ​ | — | ​ | $- | ​ | 1,539,085 | ​ | 760,915 | ​ |
| August 1-31, 2025 | ​ | 26,200 | ​ | ​ 77.06 | ​ | 1,565,285 | ​ | 734,715 | ​ |
| September 1-30, 2025 | ​ | 89,535 | ​ | ​ 77.85 | ​ | 1,654,820 | ​ | 645,180 | ​ |

## Risk factors

As filed, 366 characters.

There have been no material changes in the risk factors applicable to the Company from those disclosed in Part I, Item 1A., “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Please refer to that section of the Company’s Form 10-K for disclosures regarding the risks and uncertainties related to the Company’s business.

Filed Nov 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-108483. Last ingested by Listed: Nov 6, 2026, 13:15 ET. No prices; not investment advice.
